Caricamento...
Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease worldwide. Despite its high prevalence and rising incidence, there are currently no specific targeted pharmacotherapies approved by the Food and Drug Administration (FDA) for nonalcoholic steatohepatitis (NASH). Cur...
Salvato in:
| Pubblicato in: | J Clin Exp Hepatol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6926203/ https://ncbi.nlm.nih.gov/pubmed/31889754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2019.06.003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|